Black Hawk Acquisition Corp

Black Hawk Acquisition Corp was a special purpose acquisition company (SPAC) or "blank check" company incorporated for the purpose of effecting a merger, asset acquisition, or similar business combination. The company focused its search on the healthcare and biopharmaceutical industries, seeking to partner with high-growth life sciences companies. In early 2023, it announced a definitive business combination agreement with AUM Biosciences, a clinical-stage oncology company, but the merger was terminated in June 2023. Following the termination of the deal and the expiration of its permitted timeline to complete a combination, the company announced its intention to liquidate and dissolve in October 2023. During its active period, it was listed on the NASDAQ under the symbol BHAC.